Quick Takeaways
- Venrock Healthcare Capital Partners III, L.P. filed SCHEDULE 13G/A for Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE).
- Disclosed ownership: 4.6%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"Venrock Healthcare Capital Partners III, L.P. disclosed 4.6% ownership in Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 4.6% | 2,685,448 | 0 | 2,685,448 | /s/ Sherman G. Souther | By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory | |
| VHCP Co-Investment Holdings III, LLC | 4.6% | 2,685,448 | 0 | 2,685,448 | /s/ Sherman G. Souther | By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory | |
| Venrock Healthcare Capital Partners EG, L.P. | 4.6% | 2,685,448 | 0 | 2,685,448 | /s/ Sherman G. Souther | By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory | |
| VHCP Management III, LLC | 4.6% | 2,685,448 | 0 | 2,685,448 | /s/ Sherman G. Souther | By Sherman G. Souther, Authorized Signatory | |
| VHCP Management EG, LLC | 4.6% | 2,685,448 | 0 | 2,685,448 | /s/ Sherman G. Souther | By Sherman G. Souther, Authorized Signatory | |
| Nimish Shah | 4.6% | 2,685,448 | 0 | 2,685,448 | /s/ Sherman G. Souther | By Sherman G. Souther, Attorney-in-fact | |
| Bong Y Koh | 4.6% | 2,685,448 | 0 | 2,685,448 | /s/ Sherman G. Souther | By Sherman G. Souther, Attorney-in-fact |